These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26052398)

  • 1. Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease.
    Russo FP; Rodríguez-Castro K; Scribano L; Gottardo G; Vanin V; Farinati F
    World J Hepatol; 2015 May; 7(8):1097-104. PubMed ID: 26052398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
    Rapti I; Hadziyannis S
    World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?
    Abu-Amara M; Feld JJ
    Semin Liver Dis; 2013 May; 33(2):157-66. PubMed ID: 23749672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.
    Yang HC; Kao JH
    Emerg Microbes Infect; 2014 Sep; 3(9):e64. PubMed ID: 26038757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal.
    Vallet-Pichard A; Pol S
    Therap Adv Gastroenterol; 2014 Jul; 7(4):148-55. PubMed ID: 25057295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    European Association for the Study of the Liver
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New horizon for radical cure of chronic hepatitis B virus infection.
    Tajiri K; Shimizu Y
    World J Hepatol; 2016 Jul; 8(21):863-73. PubMed ID: 27478536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.
    Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
    Aliment Pharmacol Ther; 2018 Jan; 47(1):43-54. PubMed ID: 29035003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection.
    Chae HB; Hann HW
    Ther Clin Risk Manag; 2007 Aug; 3(4):605-12. PubMed ID: 18472982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Hepatitis B Core-Related Antigen.
    Inoue T; Tanaka Y
    Genes (Basel); 2019 May; 10(5):. PubMed ID: 31075974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B].
    Zhang Y; Peng L; Cao Y; Zeng Z; Wu Y; Shi H; Chen S; Guo J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):512-6. PubMed ID: 26398842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
    Honda M; Shirasaki T; Terashima T; Kawaguchi K; Nakamura M; Oishi N; Wang X; Shimakami T; Okada H; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    J Infect Dis; 2016 Apr; 213(7):1096-106. PubMed ID: 26621908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
    Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
    J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of HBV and HBV/HDV-Associated Liver Cirrhosis.
    Höner Zu Siederdissen C; Cornberg M
    Visc Med; 2016 Apr; 32(2):86-94. PubMed ID: 27413725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future directions for treating hepatitis B virus infection.
    Tawada A; Kanda T; Yokosuka O
    World J Hepatol; 2015 Jun; 7(11):1541-52. PubMed ID: 26085913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet Needs in Clinical and Basic Hepatitis B Virus Research.
    Su TH; Kao JH
    J Infect Dis; 2017 Nov; 216(suppl_8):S750-S756. PubMed ID: 29156048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.